Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Preferred Dividends : $0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Takeda Pharmaceutical Co's preferred dividends for the three months ended in Mar. 2024 was $0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2024 was $0 Mil.

Takeda Pharmaceutical Co Preferred Dividends Historical Data

The historical data trend for Takeda Pharmaceutical Co's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Preferred Dividends Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Preferred Dividends

Get a 7-Day Free Trial

Takeda Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Takeda Pharmaceutical Co Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Takeda Pharmaceutical Co (NYSE:TAK) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

TKPHF:USA TAK:Mexico 4502:Japan 4502:Japan 4502:Japan 4502:Japan TKDA:Germany TKD:Germany TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.